The safety of cell saver washing all shed mediastinal blood before re-transfusing it to the patient
Perfusion · 2025
DOI: 10.1177/02676591241297545 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perfusion, 2025. Verfasst von Sara Scicluna und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery Anesthesia and Intensive Care, Department of Clinical Science, Skåne University Hospital, Lund, Sweden. Hauptthemen laut MEDLINE: Cardiopulmonary Bypass, Coronary Artery Bypass, Blood Transfusion, Autologous, Operative Blood Salvage. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Government Compensation to County Councils for Costs Arising from Research and Education.
Abstract (Originalsprache)
Introduction
Cardiotomy suction blood is used in cardiopulmonary bypass (CPB) surgery to maintain blood volume in the CPB system, although it is known to contain micro emboli, cytokines and free plasma hemoglobin. Our aim was to investigate whether cell saver washing the cardiotomy suction blood before re-transfusing it is safe.
Methods
This is a retrospective study of 1671 elective coronary artery bypass patients, 209 of whom had their pericardial blood processed in a cell saver (Ce-S group). PS matching was performed with patients who had their pericardial blood returned back to the CPB-system by the cardiotomy suction (Ca-S group). Perioperative transfusion requirements, surgical outcome, postoperative lab data and mortality were then compared.
Results
There were no differences in baseline characteristics or EuroSCORE between the groups. The number of patients requiring transfusions did not differ, but the patients in the Ca-S group received more platelets (0.34 ± 1.0 vs 0.16 ± 0.7 units, p = .03) than in the Ce-S group. CRP (c-reactive protein) levels at day 2 and 4 were higher in the Ca-S group (174.8 ± 67.2 and 148.9 ± 74.3 mg/L vs 160.1 ± 64.6 and 125.9 ± 67.2 mg/L, p = .03, p = .002) and so were ASAT (aspartate aminotransferase) levels (0.97 ± 0.8 vs 0.81 ± 0.6 μkat/L, p = .03). Mortality, postoperative ventilation time, stroke, mediastinal infections and length of stay in the ICU were the same in both groups.
Conclusions
In this retrospective study of patients undergoing elective CABG surgery, washing the cardiotomy suction blood before re-transfusion was not associated with higher risk of allogenic blood transfusion, postoperative stroke, mediastinal infections, or 30- and 365-days mortality. Clinical registration number LU EPN 2016/4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery Anesthesia and Intensive Care, Department of Clinical Science, Skåne University Hospital, Lund, Sweden.
- Department of Medical Imaging and Physiology, Skåne University Hospital, Lund, Sweden.
- Clinical Physiology and Nuclear Medicine, Lund University, Lund, Sweden.
ORCID-Profile: Sara Scicluna
Förderung
- Government Compensation to County Councils for Costs Arising from Research and Education
Zitieren
APA
Scicluna, S., Dencker, M., & Bjursten, H. (2025). The safety of cell saver washing all shed mediastinal blood before re-transfusing it to the patient. Perfusion. https://doi.org/10.1177/02676591241297545
Vancouver
Scicluna S, Dencker M, Bjursten H. The safety of cell saver washing all shed mediastinal blood before re-transfusing it to the patient. Perfusion. 2025. doi:10.1177/02676591241297545
BibTeX
@article{Scicluna2025,
author = {Scicluna, Sara and Dencker, Magnus and Bjursten, Henrik},
title = {The safety of cell saver washing all shed mediastinal blood before re-transfusing it to the patient},
journal = {Perfusion},
year = {2025},
doi = {10.1177/02676591241297545}
}
EUVIMED